FibroBiologics (FBLG) EGM 2026 summary

Opening remarks and agenda

• Meeting called to order with introductions of board members and executive team.

• Agenda included formal business, corporate update, and Q&A session.

Specific resolutions to be voted on

• Approval of a reverse stock split at a ratio between 1-for-5 and 1-for-30, at board discretion within one year.

• Approval for issuance of up to 12,110,203 shares upon exercise of warrants from a November 18, 2025 agreement.

• Approval for issuance of up to 4,477,614 shares and 313,433 shares upon exercise of warrants from November 24 and November 10, 2025 agreements.

• Approval for issuance of up to 5,227,275 shares and 365,909 shares upon exercise of warrants from December 14, 2025 agreements.

• Approval to adjourn the meeting if necessary to solicit additional votes or establish a quorum.

Overview of voting outcomes

• All five proposals, including the reverse stock split and share issuances, were approved.

• Adjournment proposal also approved; results to be reported in a Form 8-K within four business days.